Fusion of Wild-Type Mesoangioblasts with Myotubes of mtDNA Mutation Carriers Leads to a Proportional Reduction in mtDNA Mutation Load

por Zelissen, Ruby, Ahmadian, Somaieh, Montilla-Rojo, Joaquin, Timmer, Erika, Ummelen, Monique, Hopman, Anton, Smeets, Hubert, van Tienen, Florence
Publicado 2023

Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy

por van Tienen, Florence, Zelissen, Ruby, Timmer, Erika, van Gisbergen, Marike, Lindsey, Patrick, Quattrocelli, Mattia, Sampaolesi, Maurilio, Mulder-den Hartog, Elvira, de Coo, Irenaeus, Smeets, Hubert
Publicado 2019